BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7437318)

  • 1. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
    Sonnex TS; Carrington P; Norris P; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo mobilization of polymorphonuclear leukocytes in psoriasis: relationship to clinical parameters and serum inhibitory factors.
    Tigalonowa M; Glinski W; Jablonska S
    J Invest Dermatol; 1983 Jul; 81(1):6-9. PubMed ID: 6863981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?
    Langner A; Chorzelski TP; Fraczykowska M; Jabłońska S; Symańczyk
    Arch Dermatol Res; 1983; 275(4):226-8. PubMed ID: 6625647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses.
    Schröder JM; Szperalski B; Koh CJ; Christophers E
    J Invest Dermatol; 1981 Dec; 77(6):464-8. PubMed ID: 7310170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients.
    Pigatto PD; Radaelli A; Tadini G; Polenghi MM; Brambilla L; Altomare G; Carandente F
    Arch Dermatol Res; 1985; 277(3):185-9. PubMed ID: 4015183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of monocyte chemotactic activity in the sera of psoriatic patients after heat treatment.
    Isoda M; Hidaka K
    J Dermatol; 1987 Feb; 14(1):29-32. PubMed ID: 3301947
    [No Abstract]   [Full Text] [Related]  

  • 15. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Pease CT; Fennell M; Staughton RC; Brewerton DA
    Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functions of polymorphonuclear leukocytes emigrating into the skin.
    Csato M; Dobozy A; Raith L; Simon N
    Acta Derm Venereol; 1985; 65(2):106-10. PubMed ID: 2408410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.